ATE282414T1 - Neue verwendung von levosimendan - Google Patents

Neue verwendung von levosimendan

Info

Publication number
ATE282414T1
ATE282414T1 AT00969616T AT00969616T ATE282414T1 AT E282414 T1 ATE282414 T1 AT E282414T1 AT 00969616 T AT00969616 T AT 00969616T AT 00969616 T AT00969616 T AT 00969616T AT E282414 T1 ATE282414 T1 AT E282414T1
Authority
AT
Austria
Prior art keywords
levosimendan
new use
treatment
propanedinitrile
hydrazono
Prior art date
Application number
AT00969616T
Other languages
English (en)
Inventor
Lasse Lehtonen
Mikhail Ruda
Jeffrey Hosenpud
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of ATE282414T1 publication Critical patent/ATE282414T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00969616T 1999-10-22 2000-10-20 Neue verwendung von levosimendan ATE282414T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI992298 1999-10-22
PCT/FI2000/000915 WO2001028560A1 (en) 1999-10-22 2000-10-20 A new use of levosimendan

Publications (1)

Publication Number Publication Date
ATE282414T1 true ATE282414T1 (de) 2004-12-15

Family

ID=8555494

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00969616T ATE282414T1 (de) 1999-10-22 2000-10-20 Neue verwendung von levosimendan

Country Status (9)

Country Link
US (1) US6911209B1 (de)
EP (1) EP1248620B1 (de)
JP (1) JP2003512328A (de)
AT (1) ATE282414T1 (de)
AU (1) AU7928700A (de)
CA (1) CA2387920C (de)
DE (1) DE60016038T2 (de)
ES (1) ES2231277T3 (de)
WO (1) WO2001028560A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132275B2 (en) 2010-11-18 2015-09-15 Cardiac Pacemakers, Inc. Automatic determination of chronotropic incompetence using atrial pacing at rest
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5969017A (en) 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia

Also Published As

Publication number Publication date
AU7928700A (en) 2001-04-30
US6911209B1 (en) 2005-06-28
CA2387920A1 (en) 2001-04-26
EP1248620A1 (de) 2002-10-16
ES2231277T3 (es) 2005-05-16
DE60016038T2 (de) 2005-12-22
JP2003512328A (ja) 2003-04-02
WO2001028560A1 (en) 2001-04-26
DE60016038D1 (de) 2004-12-23
EP1248620B1 (de) 2004-11-17
CA2387920C (en) 2008-08-26

Similar Documents

Publication Publication Date Title
YU48767B (sh) (-)-[[4-(1,4,5,6-tetrahidro-4-metil-6-okso-3-piridazinil)fenil]hidrazono]propandinitril, postupak za njegovo dobijanje i intermedijeri
CA2134972A1 (en) Anti-ischemic medicament
PT988302E (pt) Benzonaftiridinas
DE60016038D1 (de) Neue verwendung von levosimendan
EE04355B1 (et) Levosimendani kasutamine kopsuhüpertensiooni ravimi tootmises
EA200001098A1 (ru) Пероральные композиции с контролируемым высвобождением левозимендана
EE200000755A (et) Püridasinooni derivaadi uus kasutusvõimalus
DE60104693D1 (de) Behandlung von septischem schock
NO20016316D0 (no) Fremgangsmåte til å behandle eller forhindre kransarterietransplantasjonsvasospasme
FI972077A0 (fi) (-)-((4-(1,4,5,6-tetrahydro-4-metyyli-6-okso-3-pyridatsinyyli)-fenyyli)-hydratsono)propaanidinitriili

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties